EP4299057A1 — Solid compositions comprising a peptide or a protein and an acylated amino acid
Assigned to Adocia SAS · Expires 2024-01-03 · 2y expired
What this patent protects
The invention relates to solid composition comprising a peptide or a protein and an acylated aminoacid AC-aa, or a salt thereof, characterized in that: - the acyl group -AC comprises from 4 to 9 carbon atoms, - said composition comprises at least 300 mg/g of AC-aa relative to t…
USPTO Abstract
The invention relates to solid composition comprising a peptide or a protein and an acylated aminoacid AC-aa, or a salt thereof, characterized in that: - the acyl group -AC comprises from 4 to 9 carbon atoms, - said composition comprises at least 300 mg/g of AC-aa relative to the total weight of the composition.
Drugs covered by this patent
- Ozempic (semaglutide) · Novo Nordisk
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.